Rare Diseases
From the Journals
Serotonin syndrome risk with triptans and antidepressants ‘very low’
Results cast doubt on the validity of the FDA’s advisory warning in 2006.
News from NORD
Opioid Epidemic Impacts Patients With Sarcoidosis
News from NORD
Abstracts Being Accepted for Cornelia de Lange Syndrome Foundation Symposium
News from NORD
National Health Council to Host Workshop for Patient Organizations
News from NORD
NORD Call for Abstracts Reopened
News from NORD
NORD Submits Comments to the Centers for Medicare and Medicaid Services
News from NORD
NORD Advocates for Iowa Co-pay Choice Bill
News from NORD
Letter to Congress: NORD and Others Oppose “Right to Try”
News from NORD
Rare Disease Day Events Planned for Campuses, Hospitals, and State Legislatures
News from NORD
NORD to Moderate Panel at NIH Rare Disease Day Event
From the Journals
Mogamulizumab active in HTLV-1–associated myelopathy
The phase 1-2a study shows potential for mogamulizumab in the treatment of HAM-TSP.